Capricor Therapeutics (CAPR) EPS (2010 - 2026)
Capricor Therapeutics (CAPR) EPS from Dec 31, 2010 to Mar 31, 2026. The TTM Capricor Therapeutics (CAPR) EPS is -$2.22. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Capricor Therapeutics (CAPR) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +64.90% |
| 3 Years TTM | +24.00% |
| 5 Years TTM | +22.66% |
| 10 Years TTM | -12.20% |
| All Time TTM | +4.75% |
Annual EPS change of Capricor Therapeutics (CAPR)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.59 | -67.85% |
| 2025 | -$1.83 | +106.22% |
| 2024 | -$0.89 | +24.07% |
| 2023 | -$0.72 | -37.76% |
| 2022 | -$1.15 | +38.89% |
| 2021 | -$0.83 | +24.70% |
| 2020 | -$0.66 | -54.58% |
| 2019 | -$1.46 | -69.80% |
| 2018 | -$4.84 | -3.04% |
| 2016 | -$4.99 | -36.91% |
| 2015 | -$7.91 | +48.91% |
| 2014 | -$5.31 | -30.15% |
| 2013 | -$7.61 | +316.59% |
| 2012 | -$1.83 | +48.58% |
| 2011 | -$1.23 | -29.43% |
| 2010 | -$1.74 | N/A |
Comparison Capricor Therapeutics (CAPR) five years EPS CAGR with competitors
Capricor Therapeutics (CAPR) five years EPS CAGR is 22.65%.